IndraLab

Statements



reach
"Having demonstrated that OTUB2/SNX29P2 causes impaired glycolysis and increased OXPHOS in ovarian cancer cells, we then identified the mediator of this function."

reach
"Activation of CA9 restores OTUB2-mediated inhibition of glycolysis and tumor growth; thus, CA9 inhibitors might be a promising strategy for ovarian cancer treatment."

reach
"OTUB2/SNX29P2 Suppresses Glycolysis and Promotes OXPHOS in Ovarian Cancer.."

reach
"The results of gene set enrichment analysis (GSEA) indicated that overexpression of either OTUB2 or SNX29P2 suppresses the glycolysis pathway and enhances OXPHOS activity (Fig. 4 A and B)."

reach
"Overexpression of OTUB2 or SNX29P2 in ES-2 cells inhibited glycolysis and lactate production while increasing OXPHOS (Fig. 4 C–E and SI Appendix, Fig. S4 A–C)."